Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India PSU Equity Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Invesco India PSU Equity FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseInvescoHDFC
NAV₹76.3600₹23.6750
NAV date20 Nov 202620 Nov 2026
History13.9 years3.1 years
Expense ratio1.2%1.1%
Stars★★★★★★★★★★
Growth Score51.5094.50

Returns

Invesco India PSU Equity FundHDFC Pharma and Healthcare Fund
1 month+4.15%+12.97%
3 months−3.51%+7.13%
6 months−2.65%+17.84%
YTD−3.29%+33.73%
1 year−4.19%+32.20%
3 years (CAGR)+17.36%+30.70%
5 years (CAGR)+20.13%—
10 years (CAGR)+16.18%—
Since launch+15.43%+31.83%

Risk

Invesco India PSU Equity FundHDFC Pharma and Healthcare Fund
Volatility23.6%15.8%
Downside volatility14.3%8.5%
Sharpe0.461.53
Sortino0.762.86
Calmar0.582.06
Return / risk0.741.95
Deepest fall−33.42%−14.91%
Days to recover289126
Below its high−8.06%+0.00%

Against benchmark

Invesco India PSU Equity FundHDFC Pharma and Healthcare Fund
Alpha—+7.54%
Beta—0.97
R²—85.0%
Up capture—108.9%
Down capture—71.0%
Tracking error—6.1%
Information ratio—1.17
Treynor—0.24

Consistency

Invesco India PSU Equity FundHDFC Pharma and Healthcare Fund
Best 1-year+116.73%+67.01%
Middle 1-year+14.92%+23.25%
Worst 1-year−23.48%+1.71%
1-year periods with a loss23.0%0.0%
Middle 3-year+18.21%+30.22%
Positive months55.6%72.2%
Best day+6.78%+3.18%
Worst day−14.78%−3.61%
Worst 5% day−2.16%−1.51%
Positive days55.7%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Invesco India PSU Equity FundHDFC Pharma and Healthcare Fund
5-year XIRR+17.43%—
5-year value₹9,35,042—
3-year XIRR+4.67%+27.71%
1-year XIRR−3.90%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth